In 2025, U.S. health insurers face surging medical expenses driven by rising prescription drug costs, particularly from GLP-1 weight-loss medications, prompting coverage reevaluation.

Learn how GLP-1 medications like Ozempic are influencing life and health insurance underwriting and premium pricing.